The Impact of Glucocorticoid Replacement Regimens on Metabolic Outcome and Comorbidity in Hypopituitary Patients

2006318 citationsJournal Article

Authors

Helena Filipsson Nyström · University of Gothenburg

John P. Monson · Queen Mary University of London

Maria Kołtowska‐Häggström · Uppsala University

Gudmundur Johannsson · University of Gothenburg

Abstract

HCeq doses of at least 20 mg/d in adults with hypopituitarism are associated with an unfavorable metabolic profile. CA replacement may have metabolic advantages compared with other GCs.

Topics & Keywords

Growth Hormone and Insulin-like Growth Factors Adrenal Hormones and Disorders Hormonal Regulation and Hypertension

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The Journal of Clinical Endocrinology & Metabolism

Volume 91, Issue 10, pp. 3954-3961

DOI: 10.1210/jc.2006-0524

Field-Weighted Citation Impact: 5.53